Celltrion   Report issue

Founded: Incheon Korea, Republic of (2002)
Status: No NME R&D (2002)

Organization Overview

First Clinical Trial
2010
NCT01084863
First Marketed Drug
2002
famotidine (pepcid)
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Celltrion | CELLTRION | Celltrion Inc. | Celltrion, Inc. | CELLTRION, Inc. | CELLTRION INC